 VANCOUVER, British Columbia-- BUSINESS WIRE --Zymeworks Inc. NYSE: ZYME, a clinical-stage biopharmaceutical company developing next-generation multifunctional biotherapeutics, today announced that management will participate in an upcoming investor conference: 